Charles Couineau

Global Analytics and Insights Director, Oncology - Advanced Nsclc @阿斯利康

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2024 — Present

Global Analytics and Insights Director, Oncology - Advanced Nsclc @阿斯利康

View department →

Cambridge, GB

Global commercial insights and analytics lead for DATROWAY NSCLC indications. Core stakeholder for AVANZAR launch readiness.Overseeing the 1L and 2L+ mNSCLC EGFRwt indications across the Lung portfolio. In particular, full core team member and GA & I lead for all the DATROWAY NSCLC indications.

EDUCATION

2024 — 2024

HMX – Harvard Medical School

HMX Pro Pharmacology - Clinical Drug Development

2000 — 2004

ESSEC Business School

Diplôme ESSEC, Business

2024 — 2024

HMX – Harvard Medical School

HMX Pro - Genetics - Genetic Testing and Sequencing Technologies

SKILLS

Mergers & AcquisitionsDue DiligenceManagementCorporate FinanceAuditingIfrs

ABOUT CHARLES COUINEAU

12 years pharma experience both in affiliate and headquarters level for 2 big pharmas. Very strong oncology knowledge and expertise. Effective at collaboration and influence within an international business setting; often sought out as partner of choice to manage complex strategic business cases. A skilled communicator, able to lead discussions and deliver desired results.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Charles Couineau — Global Analytics and Insights Director, Oncology - Advanced Nsclc at 阿斯利康 in London, GB | Unifers